Dear Friend,
Welcome back to our most recent
newsletter. We have some important updates for you, and an overview of
the best parts of September.
What’s
Happened Since Last Time
-
The collection and testing of tissue
is an ongoing process. While we are waiting for our current tissue
supplier to provide the remaining tissue, we are happy to report that our attendance
of the São Paulo conference found two potential, additional sources of
tissue in South America.
-
As we work on acquiring more tissue,
Foregen is pursuing several research opportunities as a part of Phase
III of our roadmap, and function as complementary components. As such, we are in
the exploratory stages of acquiring the resources to conduct a
histological study of the foreskin with modern techniques, as well as
other important potential research opportunities. Tissue priority will
be applied to Phase II animal trials.
-
Foregen will be conducting an AMA (Ask
Me Anything) on Reddit from 2-4 p.m. CST on Sunday, October 6th. If
you have questions be sure to drop by, and also read the post here with more details.
-
Our partner organization, Droit au
Corps, tells us that they are increasing their cooperation with
American groups; indeed they have assembled numerous organizations and
allies to support their petition. You can see the list and sign it on
the page here.
- Over the
past month Foregen also had over 170 new supporters sign up on our
site expressing interest in the project.
-
For the month of September we reached
a total of $9,227 in donations, which helps us move forward with the
next parts of our mission! Be sure to inform other activists, friends
and family about Foregen and the science we’re pursuing to one day
help provide genital integrity to men around the world. Our overall
total to date is $509,412 Let’s keep it up.
Tell Me
Something Interesting
-
This article discusses how artificially grown human
organs are seen by many as the "holy grail" for resolving organ
shortage. A new sacrificial ink-writing technique from Harvard allows
3D printing of large, vascularized human organ building blocks,
yielding viable, organ-specific tissues with high cell density and
function
Thanks for reading, and stay tuned
for our next newsletter. If you’d like more frequent updates, please
head over to our blog, or visit one of our social media accounts – the
links are at the bottom of this newsletter.
Best,
The Foregen Team
|